QUOTIENT SCIENCES LIMITED
Get an alert when QUOTIENT SCIENCES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-25 (in 6mo)
Last made up 2025-11-11
Watchouts
None on the register
Cash
£16M
+38.2% vs 2023
Net assets
£134M
-8.2% vs 2023
Employees
597
-8.6% vs 2023
Profit before tax
-£9M
-170.4% vs 2023
Name history
Renamed 3 times since incorporation
- QUOTIENT SCIENCES LIMITED 2017-11-08 → present
- QUOTIENT CLINICAL LIMITED 2013-12-06 → 2017-11-08
- PHARMACEUTICAL PROFILES GROUP LIMITED 2006-02-15 → 2013-12-06
- INGLEBY (1619) LIMITED 2004-09-03 → 2006-02-15
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £74,270,000 | £71,340,000 | |
| Operating profit | £10,545,000 | £9,191,000 | |
| Profit before tax | £12,614,000 | -£8,879,000 | |
| Net profit | £10,544,000 | -£12,029,000 | |
| Cash | £11,518,000 | £15,919,000 | |
| Total assets less current liabilities | £187,086,000 | £172,800,000 | |
| Net assets | £145,808,000 | £133,779,000 | |
| Equity | £145,808,000 | £133,779,000 | |
| Average employees | 653 | 597 | |
| Wages | £26,205,000 | £26,264,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 14.2% | 12.9% | |
| Net margin | 14.2% | -16.9% | |
| Return on capital employed | 5.6% | 5.3% | |
| Current ratio | 2.56x | 2.87x | |
| Interest cover | 2.38x | 1.51x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have prepared the financial statements on the going concern basis, as they do not intend to liquidate the Company or to cease its operations. They have also concluded that there are no material uncertainties that could have cast significant doubt over their ability to continue as a going concern for at least 12 months from the date of approval of the financial statements.”
Group structure
- QUOTIENT SCIENCES LIMITED · parent
- Quotient Sciences (Alnwick) Limited 100%
Significant events
- “The Company experienced a challenging year in 2024 as revenues were impacted by macro-economic factors associated with the broader life sciences market but, because of significant cost reduction initiatives implemented throughout the period, the Company enters 2025 with a reduced cost structure and a solid base from which to deliver increased revenues and margins going forward.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GLASS, Desmond Kenneth Neil | Director | 2022-05-18 | Nov 1969 | Irish |
| NIEUWENHOVE, Thierry Andre Van | Director | 2023-10-16 | Mar 1973 | Belgian |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CAMERON, Gordon Biggart | Secretary | 2011-02-03 | 2022-05-18 |
| CAMERON, Gordon Biggart | Secretary | 2008-12-15 | 2010-03-03 |
| DOWNING, Ian | Secretary | 2006-01-01 | 2008-12-15 |
| KENNEDY, Michelle | Secretary | 2010-03-03 | 2011-02-03 |
| SOUSTER, Nigel Graham | Secretary | 2005-01-10 | 2005-11-16 |
| INGLEBY NOMINEES LIMITED | Corporate Secretary | 2004-09-03 | 2005-01-10 |
| BELL, James Angus | Director | 2005-01-10 | 2008-12-15 |
| BURDETT, Roger Leonard | Director | 2010-10-20 | 2013-12-09 |
| CAMERON, Gordon Biggart | Director | 2008-12-15 | 2022-05-18 |
| COWAN, Desmond Joseph Paul Edward | Director | 2008-12-15 | 2010-10-20 |
| DOWNING, Ian | Director | 2006-01-01 | 2008-12-15 |
| EGERTON, Mark, Dr | Director | 2013-12-09 | 2023-10-16 |
| EGERTON, Mark, Doctor | Director | 2005-08-01 | 2008-12-15 |
| LEE, Simon Anthony | Director | 2005-01-10 | 2008-12-15 |
| MOSES, Edwin, Dr | Director | 2005-01-10 | 2008-12-15 |
| RANKIN, Andrew | Director | 2007-11-01 | 2008-12-17 |
| SOUSTER, Nigel Graham | Director | 2005-01-10 | 2005-11-16 |
| INGLEBY HOLDINGS LIMITED | Corporate Director | 2004-09-03 | 2005-01-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Quad Uk Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-12-16 | Active |
| Watch Bidco Limited | Legal person | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-09 | Ceased 2020-12-16 |
| Ascot Bidco Limited | Corporate entity | Significant influence | 2016-04-06 | Ceased 2016-12-09 |
Filing timeline
Last 20 of 135 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-09-23 | AA | accounts | Accounts with accounts type full | |
| 2024-12-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-26 | AA | accounts | Accounts with accounts type full | |
| 2023-11-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-21 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-17 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-04 | AA | accounts | Accounts with accounts type full | |
| 2023-01-20 | CH01 | officers | Change person director company with change date | |
| 2023-01-20 | CH01 | officers | Change person director company | |
| 2022-11-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-29 | AA | accounts | Accounts with accounts type full | |
| 2022-05-20 | TM01 | officers | Termination director company with name termination date | |
| 2022-05-20 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-05-20 | AP01 | officers | Appoint person director company with name date | |
| 2021-10-25 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-06-24 | AA | accounts | Accounts with accounts type full | |
| 2021-03-08 | SH01 | capital | Capital allotment shares | |
| 2021-01-28 | AA01 | accounts | Change account reference date company previous shortened |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-3.9%
£74,270,000 £71,340,000
-
Cash
+38.2%
£11,518,000 £15,919,000
-
Net assets
-8.2%
£145,808,000 £133,779,000
-
Employees
-8.6%
653 597
-
Operating profit
-12.8%
£10,545,000 £9,191,000
-
Profit before tax
-170.4%
£12,614,000 -£8,879,000
-
Wages
+0.2%
£26,205,000 £26,264,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers